HMC continues patient safety improvements with a Medication Safety Symposium 2017

Press release
Published March 6th, 2017 - 10:13 GMT

During the event
During the event

Hamad Medical Corporation (HMC) recently held a Medication Safety Symposium 2017 to build on improving patient safety in the region by focusing on medication safety best practice and continuous quality improvement.

The symposium, which was endorsed by the International Medication Safety Network (IMSN) and Institutes for Safe Medication Practices USA (ISMP) and Canada (ISMP Canada), attracted over 350 delegates and built on the success of previous HMC events.

The HMC Medication Safety Symposium 2017 brought together a group of regional experts and leaders in the field of medication safety. Speakers from a variety of healthcare sectors spoke about the best medication safety practices in the region, pharmacovigilance (the practice of monitoring the effects of medical drugs) and its importance to Qatar, medication use research and several other patient safety initiatives. Key speakers included Dr. Rabih Dabliz, Manager for Quality and Medication Safety Services at Cleveland Clinic Abu Dhabi;  Dr. Adel Alharf, Executive Director for Vigilance and Benefit / Risk Assessment Directorate at the Saudi Food and Drug Authority (SFDA) and Dr. Amr Saad, the former Associate Minister of Health for Pharmaceutical Affairs and Founder of the Egyptian Pharmaceutical Vigilance Center.

Dr. Moza Al Hail, Executive Director of Pharmacy at HMC said “This symposium was a great opportunity for healthcare providers, researchers, and aspiring pharmacists in Qatar to come together and engage in discussions on medication safety to stimulate enhanced health outcomes. The symposium consolidates HMC’s commitment to providing the safest, most effective and most compassionate care to each and every one of our patients, giving delegates the chance to identify the best medication safety strategies and learn innovative ways of ensuring the safe use of medications.” 

The symposium was an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department and approved for seven Continuing Professional Development hours.

Background Information

Hamad Medical Corporation

Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East.

For more than four decades, HMC has been dedicated to delivering the safest, most effective and compassionate care to all its patients.

Check out our PR service


Signal PressWire is the world’s largest independent Middle East PR distribution service.

Subscribe

Sign up to our newsletter for exclusive updates and enhanced content